SpringWorks Therapeutics Announces Dosing of First Patient in Phase 1b Combination Study Evaluating Nirogacestat and Janssen’s BCMA Bispecific Antibody Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Matthew Durham
Omnidynamic Marketing

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing